Delivery Order SPE2DB22D1002-SPE2DB25FKXQ6
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.88 firm-fixed-price delivery order is for the supply of insulin degludec pens (U-200, 3mL) to support military healthcare programs. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,710.72 firm fixed price contract is for the supply of insulin degludec pens (U-100, 3 mL) to support military treatment facilities and federal healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-100, 3 mL). The contract is a delivery order with a firm fixed price of $1,288.93 and a completion date of May 13, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for...
The U.S. Department of Defense (DOD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,184,917 units of Insulin Degludec Pens (U-200) 3ML. The contract, valued at $4,137.57, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,125.39, is for the delivery of insulin degludec pens (U-200, 3ML) to support military healthcare programs. The contract has an ultimate completion date of October 29, 2024 and is structured as a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,930.60, is for the procurement of insulin degludec pens (U-200) in 3 milliliter sizes. The contract is a firm-fixed price delivery order with a completion date of February 20, 2024. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,510.61, is for the delivery of 4562539411 INSULIN DEGLUDEC PEN (U-200) 3ML. The contract has a firm fixed price and an ultimate completion date of October 20, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,313.56 for the supply of Insulin Degludec Pen (U-200) 3ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies...
This federal contract award is for the delivery of Insulin Degludec Pens (U-200) 3ML to the U.S. government. The $1,257.03 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of essential medical commodities,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,788.60 firm fixed-price delivery order is for the supply of insulin glargine-yfgn U100 pens, with a completion date of December 24, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive...